Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Denizot Y et al. Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy. 2000 Nephrol. Dial. Transplant. pmid:10978389
Clark WF et al. A novel treatment for lupus nephritis: lignan precursor derived from flax. 2000 Lupus pmid:10981647
Suzuki T et al. Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon. 2000 Eur. J. Pharmacol. pmid:10988347
Kallan NC and Halcomb RL Synthesis of the ring system of phomactin D using a Suzuki macrocyclization. 2000 Org. Lett. pmid:10990428
Turner PJ et al. Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10991932
Klabunde RE and Anderson DE Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage. 2000 Eur. J. Pharmacol. pmid:10996604
Zăgrean L et al. Preliminary EEG study of protective effects of Tebonin in transient global cerebral ischemia in rats. 1998 Jan-Jun Rom J Physiol pmid:11000876
Nieswandt B et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. 2000 Blood pmid:11001906
Gastaldello K et al. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. 2000 Nephrol. Dial. Transplant. pmid:11007834
Wratten ML et al. Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins. 2000 Artif Organs pmid:11012537
Wagner F et al. Ether lipids in the cell membrane of Mycoplasma fermentans. 2000 Eur. J. Biochem. pmid:11012682
Montrucchio G et al. Role of platelet-activating factor in cardiovascular pathophysiology. 2000 Physiol. Rev. pmid:11015622
Walther A et al. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia. 2000 J. Surg. Res. pmid:11027469
Ciesla DJ et al. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. 2000 Shock pmid:11028541
Brady M et al. Cytokines and acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030606
Imrie CW and McKay CJ The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030612
De Geest B et al. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:11031226
McLarnon JG et al. Anion channels modulate store-operated calcium influx in human microglia. 2000 Cell Calcium pmid:11032781
Fraga AG et al. Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists. 2000 Eur J Pharm Sci pmid:11033071
Choi SY et al. Capsaicin inhibits platelet-activating factor-induced cytosolic Ca2+ rise and superoxide production. 2000 J. Immunol. pmid:11034409
Simon HU et al. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. 2000 J. Immunol. pmid:11034418
Rowland BL et al. Elevated circulating concentrations of platelet activating factor in preeclampsia. 2000 Am. J. Obstet. Gynecol. pmid:11035340
Lonardoni MV et al. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. 2000 Infect. Immun. pmid:11035745
Mul FP et al. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. 2000 J. Leukoc. Biol. pmid:11037975
Gu M et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. 2000 Transplantation pmid:11045637
Poeze M et al. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. 2000 Shock pmid:11049104
Karlstad MD et al. Platelet-activating factor (PAF)-induced decreases in whole-body and skeletal muscle protein synthesis. 2000 Shock pmid:11049115
James JH and Fischer JE Are the effects of platelet-activating factor on muscle metabolism of carbohydrates, amino acids and proteins attributable mainly to epinephrine? 2000 Shock pmid:11049116
Chłopicki S et al. Residual pulmonary neutrophils are involved in vaso- and bronchoconstrictor responses to platelet activating factor in the isolated buffer-perfused rat lung. 2000 May-Jun Pol J Pharmacol pmid:11055579
Dichmann S et al. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells. 2000 J. Cell. Physiol. pmid:11056009
Peri A et al. Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. 2000 Int. J. Cancer pmid:11058867
Tiano L et al. Oxidative response and membrane modification of diabetic platelets challenged with PAF. 2000 Prostaglandins Other Lipid Mediat. pmid:11060899
Shibata K et al. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils. 2000 Prostaglandins Other Lipid Mediat. pmid:11060901
Bracco E et al. Cell-cell signaling and adhesion in phagocytosis and early development of Dictyostelium. 2000 Int. J. Dev. Biol. pmid:11061438
Biancone L et al. Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. 2000 Transplantation pmid:11063341
Okunuki H et al. Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice. 2000 Immunol. Lett. pmid:11064108
Grassi S and Pettorossi VE Role of nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2000 Neuroscience pmid:11068144
Bussolati B et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. 2000 Am. J. Pathol. pmid:11073830
Yoshimatsu Y et al. Platelet-activating factor-induced intracellular calcium waves in human uterine myometrial cells. 2000 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:11074135
Alloatti G et al. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. 2000 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11080081
Tjoelker LW and Stafforini DM Platelet-activating factor acetylhydrolases in health and disease. 2000 Biochim. Biophys. Acta pmid:11080681
Tanaka Y et al. Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats. 2000 Br. J. Pharmacol. pmid:11082118
Le Blanc K et al. Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteins. 2000 Eur. J. Haematol. pmid:11092463
Chroni A and Mavri-Vavayanni M Characterization of a platelet activating factor acetylhydrolase from rat adipocyte. 2000 Life Sci. pmid:11105997
Murakami M et al. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. 2001 J. Biol. Chem. pmid:11106649
Wechsung E and Houvenaghel A Involvement of platelet activating factor in the endotoxin-induced effects on gastrointestinal electrical activity and some haematological parameters in the conscious miniature pig. 2000 J. Vet. Pharmacol. Ther. pmid:11107007
Johnson CD et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. 2001 Gut pmid:11115824
Li N et al. Platelet-leukocyte cross talk in whole blood. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:11116075
Iwamoto H et al. Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. 2000 Transplant. Proc. pmid:11119873
Hickey MJ et al. L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. 2000 J. Immunol. pmid:11120848
Kaplan R et al. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease. 2000 Br. J. Haematol. pmid:11122160
Bussolati B et al. IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). 2000 Clin. Exp. Immunol. pmid:11122257
Kelly RF Current strategies in lung preservation. 2000 J. Lab. Clin. Med. pmid:11128744
Adams JM et al. G-protein receptor responses in trauma neutrophils. 2000 J Trauma pmid:11130495
Asimakopoulos G et al. Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin. 2000 Perfusion pmid:11131212
Tavakoli S et al. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11133502
Clavijo LC et al. PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. 2001 J. Appl. Physiol. pmid:11133918
Galimi F et al. Hepatocyte growth factor is a regulator of monocyte-macrophage function. 2001 J. Immunol. pmid:11145707
Arese M et al. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. 2001 J. Immunol. pmid:11145723
Rabinowitz SS et al. Platelet-activating factor in infants at risk for necrotizing enterocolitis. 2001 J. Pediatr. pmid:11148517
Kwan ML et al. Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11159008
Komori M et al. PAF mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11159026
Stojanov T and O'Neill C In vitro fertilization causes epigenetic modifications to the onset of gene expression from the zygotic genome in mice. 2001 Biol. Reprod. pmid:11159375
Roudebush WE et al. Impact of blood serum insulin-like growth factor I on platelet-activating factor in bull spermatozoa. 2001 Domest. Anim. Endocrinol. pmid:11164329
Giménez R and Aguilar J Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. 2001 Neurosci. Lett. pmid:11165772
Goudevenos J et al. Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty. 2001 Eur. J. Clin. Invest. pmid:11168434
Rodrigo L et al. Hydrolysis of platelet-activating factor by human serum paraoxonase. 2001 Biochem. J. pmid:11171072
Magai RM and Shukla SD Metabolic fate of [14C]-ethanol into endothelial cell phospholipids including platelet-activating factor, sphingomyelin and phosphatidylethanol. 2001 Jan-Feb J. Biomed. Sci. pmid:11173988
Zaitseva L et al. Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock. 2000 Bull. Exp. Biol. Med. pmid:11177271
Del Sorbo L et al. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 2001 Eur. J. Immunol. pmid:11180101
Herrero-Fresneda I et al. Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. 2000 Transplantation pmid:11190497
Yildirim G et al. Effects of platelet-activating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. 2000 Undersea Hyperb Med pmid:11191161
Kecskeméti V and Balogh I The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. 2000 J. Physiol. Pharmacol. pmid:11192945
Karasawa K [Physiological role of novel metabolic pathway of platelet-activating factor(PAF): PAF-dependent transacetylation]. 2001 Tanpakushitsu Kakusan Koso pmid:11193332
Urasaki T et al. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway. 2001 J. Leukoc. Biol. pmid:11200053
Hauser CJ et al. PAF-mediated Ca2+ influx in human neutrophils occurs via store-operated mechanisms. 2001 J. Leukoc. Biol. pmid:11200069
Jeon SY et al. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. 2001 Ann. Otol. Rhinol. Laryngol. pmid:11201815
Baker RR and Chang HY The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: the control of nuclear lyso platelet-activating factor metabolism. 2000 Mol. Cell. Biochem. pmid:11204449
Mannori G et al. Interaction of tumor cells with vascular endothelia: role of platelet-activating factor. 2000 Clin. Exp. Metastasis pmid:11206844
Bassi F et al. Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. 2001 J. Periodontol. pmid:11210074
Ko TC et al. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. 2001 Bioorg. Med. Chem. Lett. pmid:11212091
Taggart DP Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation. 2001 Ann. Thorac. Surg. pmid:11216754
Lash GE and Legge M Localization and distribution of platelet activating factor receptors in the mouse ovary and oviduct during the estrous cycle and early pregnancy. 2001 Am. J. Reprod. Immunol. pmid:11216875
Sun Z et al. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. 2001 Scand. J. Gastroenterol. pmid:11218240
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Kawaguchi A et al. Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity. 2001 Life Sci. pmid:11228102
Tokumura A et al. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. 2000 Biofactors pmid:11237195
Persidsky Y et al. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. 2001 J. Neuroimmunol. pmid:11240016
Bachert C Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. 2001 Allergy pmid:11243500
Gandhi CR et al. A23187 causes release of inositol phosphates from cultured rat Kupffer cells. 2001 Eur. J. Pharmacol. pmid:11245846
Petty HR and Kindzelskii AL Dissipative metabolic patterns respond during neutrophil transmembrane signaling. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11248046
Denis MA et al. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. 2001 Scand. J. Gastroenterol. pmid:11252412
Wittwer T et al. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation. 2001 J. Heart Lung Transplant. pmid:11257563
Chen YG et al. Lignans from Kadsura angustifolia. 1998 J Asian Nat Prod Res pmid:11261213
Gu M et al. Role of platelet-activating factor in hepatectomy with Pringle's maneuver. 2001 J. Surg. Res. pmid:11266278
Iwazaki S et al. FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs. 2001 Jan-Feb Hepatogastroenterology pmid:11268964
Gujrati VR and Sastry BV Metabolic fate of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by human spermatozoa: biosynthesis and biodegradation. 2001 Life Sci. pmid:11270625
Zeng S et al. Platelet activating factor-induced P-selectin expression in platelets and its related signal transduction. 1999 Zhongguo Yao Li Xue Bao pmid:11270998
Ulrich CD Lexipafant in severe acute pancreatitis: the final word? 2001 Curr Gastroenterol Rep pmid:11276374
Beales IL Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. 2001 Dig. Dis. Sci. pmid:11284466